JP2009504149A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009504149A5 JP2009504149A5 JP2008525615A JP2008525615A JP2009504149A5 JP 2009504149 A5 JP2009504149 A5 JP 2009504149A5 JP 2008525615 A JP2008525615 A JP 2008525615A JP 2008525615 A JP2008525615 A JP 2008525615A JP 2009504149 A5 JP2009504149 A5 JP 2009504149A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- polynucleotide
- acid sequence
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 28
- 102000004196 processed proteins & peptides Human genes 0.000 claims 28
- 108090000765 processed proteins & peptides Proteins 0.000 claims 28
- 108091033319 polynucleotide Proteins 0.000 claims 20
- 102000040430 polynucleotide Human genes 0.000 claims 20
- 239000002157 polynucleotide Substances 0.000 claims 20
- 125000003275 alpha amino acid group Chemical group 0.000 claims 11
- 239000012634 fragment Substances 0.000 claims 7
- 101150024831 ahpC gene Proteins 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical group 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 241000186367 Mycobacterium avium Species 0.000 claims 1
- 208000026681 Paratuberculosis Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 208000021735 chronic enteritis Diseases 0.000 claims 1
- 208000037976 chronic inflammation Diseases 0.000 claims 1
- 230000006020 chronic inflammation Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70659405P | 2005-08-09 | 2005-08-09 | |
| US60/706,594 | 2005-08-09 | ||
| PCT/GB2006/002893 WO2007017635A1 (en) | 2005-08-09 | 2006-08-03 | Immunogenic constructs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009504149A JP2009504149A (ja) | 2009-02-05 |
| JP2009504149A5 true JP2009504149A5 (enExample) | 2009-08-27 |
| JP5244593B2 JP5244593B2 (ja) | 2013-07-24 |
Family
ID=36992793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525615A Expired - Lifetime JP5244593B2 (ja) | 2005-08-09 | 2006-08-03 | 免疫原性構築物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7892566B2 (enExample) |
| EP (1) | EP1913020B1 (enExample) |
| JP (1) | JP5244593B2 (enExample) |
| AT (1) | ATE466876T1 (enExample) |
| AU (1) | AU2006277828B2 (enExample) |
| CA (1) | CA2617506C (enExample) |
| DE (1) | DE602006014164D1 (enExample) |
| DK (1) | DK1913020T3 (enExample) |
| ES (1) | ES2345274T3 (enExample) |
| NZ (1) | NZ565695A (enExample) |
| WO (1) | WO2007017635A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9806093D0 (en) * | 1998-03-20 | 1998-05-20 | Taylor John Hermon | Diagnostics and vaccines for mycobacterial infections of animals and humans |
| ATE466876T1 (de) | 2005-08-09 | 2010-05-15 | Hav Vaccines Ltd | Immunogene konstrukte |
| GB201700487D0 (en) * | 2017-01-11 | 2017-02-22 | Hermon-Taylor John | Diagnostic |
| CN109125740B (zh) * | 2017-06-28 | 2022-04-05 | 成都威斯克生物医药有限公司 | 一种新型的肿瘤疫苗及其用途 |
| GB201811382D0 (en) | 2018-07-11 | 2018-08-29 | Taylor John Hermon | Vaccine |
| WO2026041756A1 (en) * | 2024-08-21 | 2026-02-26 | Hav Vaccines Limited | Treatment of crohn's disease by mycobacterium avium subsp. paratuberculosis agent |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8709803D0 (en) | 1987-04-24 | 1987-05-28 | Mcfadden J J | Treatment of crohn's disease &c |
| US5225324A (en) | 1987-04-24 | 1993-07-06 | Bioscience International, Inc. | Diagnostics for mycobacteria in public health, medical, and veterinary practice |
| FR2682967B1 (fr) | 1991-10-25 | 1994-01-14 | Pasteur Institut | Nouveau promoteur de m. paratuberculosis. son utilisation pour le clonage et l'expression de sequences nucleotidiques. |
| EP0805863A2 (en) * | 1994-12-20 | 1997-11-12 | New Zealand Pastoral Agriculture Research Institute Limited | METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN ahpCF OPERON |
| GB9526178D0 (en) | 1995-12-21 | 1996-02-21 | Taylor John Hermon | Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy |
| GB9806093D0 (en) * | 1998-03-20 | 1998-05-20 | Taylor John Hermon | Diagnostics and vaccines for mycobacterial infections of animals and humans |
| US7393540B2 (en) * | 2001-07-04 | 2008-07-01 | Health Protection Agency | Mycobacterial antigens expressed during latency |
| CN102294023A (zh) * | 2001-07-26 | 2011-12-28 | 奥塔戈创新公司 | 抗原组合物 |
| CA2473226A1 (en) * | 2002-01-11 | 2003-07-17 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
| ATE466876T1 (de) | 2005-08-09 | 2010-05-15 | Hav Vaccines Ltd | Immunogene konstrukte |
-
2006
- 2006-08-03 AT AT06765201T patent/ATE466876T1/de not_active IP Right Cessation
- 2006-08-03 CA CA2617506A patent/CA2617506C/en not_active Expired - Lifetime
- 2006-08-03 JP JP2008525615A patent/JP5244593B2/ja not_active Expired - Lifetime
- 2006-08-03 ES ES06765201T patent/ES2345274T3/es not_active Expired - Lifetime
- 2006-08-03 EP EP06765201A patent/EP1913020B1/en not_active Expired - Lifetime
- 2006-08-03 DE DE602006014164T patent/DE602006014164D1/de not_active Expired - Lifetime
- 2006-08-03 AU AU2006277828A patent/AU2006277828B2/en not_active Expired
- 2006-08-03 US US11/997,627 patent/US7892566B2/en active Active
- 2006-08-03 DK DK06765201.6T patent/DK1913020T3/da active
- 2006-08-03 NZ NZ565695A patent/NZ565695A/en unknown
- 2006-08-03 WO PCT/GB2006/002893 patent/WO2007017635A1/en not_active Ceased
-
2011
- 2011-01-14 US US13/007,062 patent/US8147850B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ealey et al. | COVID-19 and obesity: fighting two pandemics with intermittent fasting | |
| CA2638826C (en) | A mycobacterium tuberculosis fusion protein and uses thereof | |
| WO2008054540A3 (en) | Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions | |
| JPWO2019107530A5 (enExample) | ||
| JP2007515393A5 (enExample) | ||
| JP2007526248A5 (enExample) | ||
| RU2017116973A (ru) | Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса | |
| RU2016108808A (ru) | Терапевтическое применение vegf-c и ccbe1 | |
| Sibony et al. | Recent advances in Helicobacter pylori pathogenesis | |
| Hutcherson et al. | P orphyromonas gingivalis RagB is a proinflammatory signal transducer and activator of transcription 4 agonist | |
| RU2019130941A (ru) | РЕКОМБИНАНТНАЯ BCG, СВЕРХЭКСПРЕССИРУЮЩАЯ PhoP-PhoR | |
| Park et al. | PD-1 deficiency protects experimental colitis via alteration of gut microbiota | |
| Long et al. | Molecular characterization reveals involvement of four caspases in the antibacterial immunity of tongue sole (Cynoglossus semilaevis) | |
| JP2003530872A5 (enExample) | ||
| UA99094C2 (ru) | Способ лечения пациента с системной красной волчанкой | |
| Zhang et al. | Identification, expression and phylogenetic analysis of EgG1Y162 from Echinococcus granulosus | |
| JP2016507570A5 (enExample) | ||
| Hatzifoti et al. | A plasmid immunization construct encoding urease B of Helicobacter pylori induces an antigen-specific antibody response and upregulates the expression of β-defensins and IL-10 in the stomachs of immunized mice | |
| Godahewa et al. | Complement factor D homolog involved in the alternative complement pathway of rock bream (Oplegnathus fasciatus): Molecular and functional characterization and immune responsive mRNA expression analysis | |
| Alzand et al. | Campylobacter jejuni: enterocolitis and myopericarditis | |
| JP2021524485A5 (enExample) | ||
| Karna et al. | Genome sequence of a virulent Pseudomonas aeruginosa strain, 12-4-4 (59), isolated from the blood culture of a burn patient | |
| WO2019059817A9 (en) | VACCINE BASED ON FUSION PROTEIN AND PLASMIDIC DNA | |
| JP2016509018A5 (enExample) | ||
| CN103690938B (zh) | ATP合成酶β亚基在制备免疫保护剂、疫苗或抗细菌感染剂上的应用 |